dc.creator | Sciagrà R., Lubberink M., Hyafil F., Saraste A., Slart R.H.J.A., Agostini D., Nappi C., Georgoulias P., Bucerius J., Rischpler C., Verberne H.J., Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) | en |
dc.date.accessioned | 2023-01-31T09:54:46Z | |
dc.date.available | 2023-01-31T09:54:46Z | |
dc.date.issued | 2021 | |
dc.identifier | 10.1007/s00259-020-05046-9 | |
dc.identifier.issn | 16197070 | |
dc.identifier.uri | http://hdl.handle.net/11615/78865 | |
dc.description.abstract | The use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been growing during the last years, because scanners are becoming widely available and because several studies have convincingly demonstrated the advantages of this imaging approach. Therefore, there is a need of determining the procedural modalities for performing high-quality studies and obtaining from this demanding technique the most in terms of both measurement reliability and clinical data. Although the field is rapidly evolving, with progresses in hardware and software, and the near perspective of new tracers, the EANM Cardiovascular Committee found it reasonable and useful to expose in an updated text the state of the art of quantitative myocardial perfusion PET, in order to establish an effective use of this modality and to help implementing it on a wider basis. Together with the many steps necessary for the correct execution of quantitative measurements, the importance of a multiparametric approach and of a comprehensive and clinically useful report have been stressed. © 2020, The Author(s). | en |
dc.language.iso | en | en |
dc.source | European Journal of Nuclear Medicine and Molecular Imaging | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094868473&doi=10.1007%2fs00259-020-05046-9&partnerID=40&md5=2f59abd8ae02ff9a5c4f385c17b13a2b | |
dc.subject | dipyridamole | en |
dc.subject | fluorodeoxyglucose f 18 | en |
dc.subject | flurpiridaz f 18 | en |
dc.subject | nitrogen 13 | en |
dc.subject | regadenoson | en |
dc.subject | rubidium 82 | en |
dc.subject | water o 15 | en |
dc.subject | radioisotope | en |
dc.subject | arterial blood | en |
dc.subject | Article | en |
dc.subject | blood volume | en |
dc.subject | cardiac muscle | en |
dc.subject | clinical protocol | en |
dc.subject | comparative study | en |
dc.subject | coronary artery blood flow | en |
dc.subject | coronary artery disease | en |
dc.subject | coronary flow reserve | en |
dc.subject | diagnostic accuracy | en |
dc.subject | dynamic exercise | en |
dc.subject | gated imaging | en |
dc.subject | heart ejection fraction | en |
dc.subject | heart muscle blood flow | en |
dc.subject | heart muscle ischemia | en |
dc.subject | heart muscle perfusion | en |
dc.subject | heart perfusion | en |
dc.subject | human | en |
dc.subject | image quality | en |
dc.subject | image reconstruction | en |
dc.subject | limit of quantitation | en |
dc.subject | low risk population | en |
dc.subject | medical society | en |
dc.subject | myocardial perfusion imaging | en |
dc.subject | positron emission tomography-computed tomography | en |
dc.subject | practice guideline | en |
dc.subject | predictive value | en |
dc.subject | prognosis | en |
dc.subject | quantitative study | en |
dc.subject | radiation exposure | en |
dc.subject | reconstruction algorithm | en |
dc.subject | respiratory gated imaging | en |
dc.subject | sensitivity and specificity | en |
dc.subject | single photon emission computed tomography | en |
dc.subject | three-dimensional imaging | en |
dc.subject | treatment indication | en |
dc.subject | two-dimensional imaging | en |
dc.subject | cardiovascular system | en |
dc.subject | positron emission tomography | en |
dc.subject | positron emission tomography-computed tomography | en |
dc.subject | reproducibility | en |
dc.subject | Cardiovascular System | en |
dc.subject | Humans | en |
dc.subject | Myocardial Perfusion Imaging | en |
dc.subject | Positron Emission Tomography Computed Tomography | en |
dc.subject | Positron-Emission Tomography | en |
dc.subject | Radioisotopes | en |
dc.subject | Reproducibility of Results | en |
dc.subject | Springer Science and Business Media Deutschland GmbH | en |
dc.title | EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging | en |
dc.type | journalArticle | en |